Hereditary polymorphonuclear neutrophil deficiencies;Déficits héréditaires des polynucléaires neutrophiles

Transfusion Clinique et Biologique

Volumn 7, Issue 6, 2000, Pages 533-539

  Chollet Martin, S ^a   Gougerot Pocidalo, M A ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Hereditary deficiency; Leucocyte adhesion deficiency; Polymorphonuclear neutrophil; Septic granulomatosis

Indexed keywords

COTRIMOXAZOLE; ITRACONAZOLE;

ARTICLE; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL MOTILITY; CHEDIAK HIGASHI SYNDROME; ENZYME DEFICIENCY; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENETIC DISORDER; GRANULOMATOSIS; HUMAN; LEUKOCYTE ADHESION DEFICIENCY; NEUTROPENIA; NEUTROPHIL; POLYMORPHONUCLEAR CELL; PRENATAL DIAGNOSIS; PROTEIN EXPRESSION; RECURRENT INFECTION; RESPIRATORY BURST; X CHROMOSOME RECESSIVE INHERITANCE;

EID: 0034524323     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(01)80003-3     Document Type: Article

References (35)

1. Leukocyte-endothelial adhesion molecules
2. Inside the neutrophil phagosome: Oxidants, myeloperoxidase and bacterial killing
3. Genetic linkage of hyper-IgE syndrome to chromosome 4
4. Hyper-IgE syndrome with recurrent infections - An autosomal dominant multisystem disorder
5. Interleukin 4 and interferon-gamma secretion by antigen and mitogen-stimulated mononuclear cells in the hyper-IgE syndrome: No TH-2 cytokine pattern
6. Regulation of immunoglobulin production in hyper-IgE (Job's) syndrome
7. Of man and mouse: Leukocyte and endothelial adhesion molecule deficiencies
8. Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mol deficiency
9. Leukocyte adhesion deficiency: Molecular basis and functional consequences
10. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins
11. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1
12. Brief report: Recurrent severe infections caused by a novel leukocyte adhesion deficiency
13. Leukocyte adhesion deficiency type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium
14. Leukocyte adhesion deficiency type II
15. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2
16. Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1
17. Correction of leukocyte adhesion deficiency type II with oral fucose
18. Quality control in the endoplasmic reticulum: Lessons from hereditary myeloperoxidase deficiency
19. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon
20. An anomaly of neutrophil morphology with impaired function
21. Giant granules of neutrophils in Chediak-Higashi syndrome are derived from azurophil granules but not from specific and gelatinase granules
22. Genetic basis of hemophagocytic lymphohistiocytosis syndrome
23. Chediak-Higashi syndrome associated with maternal uniparental isodisomy of chromosome 1
24. Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome
25. A fatal granulomatosis of childhood. The clinical study of a new syndrome
26. Clinical features and current management of chronic granulomatous disease
27. NADPH oxidase: An update
28. X-linked chronic granulomatous disease: Mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase
29. B Cell lines as a model for inherited phagocytic diseases: Abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome
30. Granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils
31. Rebirth of granulocyte transfusions: Should it involve pediatric oncology and transplant patients?
32. Bone marrow transplantation for chronic granulomatous disease: Long-term follow-up and review of literature
33. Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease
34. Progress in gene therapy for chronic granulomatous disease